Mitsubishi UFJ Asset Management
XENE icon

Mitsubishi UFJ Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.9K Buy
1,076
+800
+290% +$44.4K ﹤0.01% 1087
2026
Q1 		$16K Hold
276
– – ﹤0.01% 1299
2025
Q4 		$12.3K Hold
276
– – ﹤0.01% 1327
2025
Q3 		$11.1K Hold
276
– – ﹤0.01% 1321
2025
Q2 		$8.64K Hold
276
– – ﹤0.01% 1362
2025
Q1 		$9.26K Hold
276
– – ﹤0.01% 1319
2024
Q4 		$11.2K Hold
276
– – ﹤0.01% 1275
2024
Q3 		$10.9K Hold
276
– – ﹤0.01% 1247
2024
Q2 		$10.8K Hold
276
– – ﹤0.01% 1207
2024
Q1 		$11.9K Buy
+276
New +$12.7K ﹤0.01% 1135

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mitsubishi UFJ Asset Management's XENE Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Xenon Pharmaceuticals (XENE) stake by 290% in Q2 2026, buying an estimated $44.4K and bringing the position to 1,076 shares worth $64.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Mitsubishi UFJ Asset Management first reported a position in XENE in Q1 2024 and has held it in 10 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 1,076 shares of Xenon Pharmaceuticals worth $64.9K as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 800 Xenon Pharmaceuticals shares in Q2 2026, an estimated $44.4K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1087 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Xenon Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.